Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CXCR3 Stable Cell Line

    [CAT#: S01YF-0923-PY46]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    CXCR3
    Target Family
    Chemokine Family
    Target Protein Species
    Human
    Host Cell Type
    HepG2;AML-12;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Immunology Research
    Related Diseases
    Cutaneous Lupus Erythematosus;Pulmonary Sarcoidosis
    Gene ID
    Human: 2833
    UniProt ID
    Human: P49682

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    CXCR3, another chemokine receptor, has been extensively studied for its role in immune responses, especially in the context of cancer and autoimmunity. The CXCL9, -10, -11/CXCR3 axis is known to regulate immune cell migration, differentiation, and activation, leading to tumor suppression. However, there are instances where this axis has been implicated in tumor growth and metastasis. In the realm of breast cancer, exercise training has been shown to improve tumor control by increasing CD8+ T-cell infiltration via CXCR3 signaling, thereby enhancing the efficacy of immune checkpoint blockade. Furthermore, CXCR3 ligands have been identified as crucial in directing the biological properties of CD4+ and CD8+ T cells in cancer and autoimmunity. Given its central role in modulating immune responses, CXCR3 and its ligands present potential therapeutic targets for various diseases, including cancer.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CXCR3 Stable Cell Line (S01YF-0923-PY46). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Timothy (Verified Customer)

    What is the role of CXCR3 in breast cancer cell migration? Dec 14 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    GNG4, which encodes the G-protein subunit γ-4, is induced following Cxcl10 treatment in breast cancer cells, suggesting a potential role in cell migration. Dec 14 2020

    chat Thomas (Verified Customer)

    How does CXCR3 signaling contribute to trigeminal neuropathic pain? Apr 17 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CXCL10 acts on CXCR3 to induce ERK and AKT activation in trigeminal ganglion neurons, contributing to the maintenance of trigeminal neuropathic pain. Apr 17 2020

    Published Data

    Fig.1 Silencing CXCR3 thwarts mitochondrial DNA harm within an in vitro model of steatohepatitis.

    An assay for oxidative mitochondrial DNA damage quantified 8-OHdG, an oxidative DNA damage marker, in AML-12 cells cultured in MCD medium and HepG2 hepatocytes treated with palmitic acid. These cells were transfected with either si-CXCR3 or si-control. The data presented here represent results from three distinct experiments, with MCD referring to methionine-and-choline-deficient and PA denoting palmitic acid.

    Ref: Du, Jinghua, et al. "Pro-inflammatory CXCR3 impairs mitochondrial function in experimental non-alcoholic steatohepatitis." Theranostics 7.17 (2017): 4192.

    Pubmed: 29158819

    DOI: 10.7150/thno.21400

    Research Highlights

    Zacharias ZR, Houtman JCD. "OMIP-099: 31-color spectral flow cytometry panel to investigate the steady-state ." Cytometry. Part A : the journal of the International Society for Analytical , 2023.
    The authors have developed a 31-color panel in order to identify and characterize the steady-state phenotype of T cells in human peripheral blood (Table 1). The panel was optimized using cryopreserved peripheral blood mononuclear cells (PBMC) and includes markers such as CD45RA, CD45RO, CCR7, and CD95 to differentiate different subpopulations of T cells (e.g., naive, T(EM), T(CM), T(EMRA), T(SCM), etc.) of CD4, CD8, and gammadelta T cells. Additionally, the panel includes markers for differentiation status (CD27, CD28), activation/antigen experience (CD11a, CD49d, CD38, HLA-DR, CD56, and CD39), co-inhibitory markers (PD-1, TIM-3), and CD4 T helper subsets (CXCR3, CXCR5, CCR4, CCR6, Foxp3, CD25, and CD127). This optimized panel offers a comprehensive evaluation of human T cell phenotype under steady-state conditions.
    Pubmed: 37814476   DOI: 10.1002/cyto.a.24799

    Singh A, et al. "CXCR3 antagonist rescues ER stress and reduces inflammation and JEV infection in ." Cytokine, 2023.
    The effect of eIF2alpha:CHOP on mitochondrial ROS generation, inflammation, and apoptotic cell death has been studied. Treatment with AMG487 was found to alleviate these effects and increase interferon (IFN)-alpha/beta production in the brains of JEV-infected mice. These findings suggest a potential therapeutic benefit of using a CXCR3 antagonist against JEV infection.
    Pubmed: 37812996   DOI: 10.1016/j.cyto.2023.156380

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare